Researchers engineered hybrid strontium sulfite nanoparticle-modified lipid nanoparticles to deliver p53 mRNA, producing ...
The Institute of Genomics and Global Health (IGH) at Redeemer’s University has concluded a 2026 Extended Reality and ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results